Reduction by gabapentin of K+-evoked release of [3H]-glutamate from the caudal trigeminal nucleus of the streptozotocin-treated rat.
about
Glutamatergic substrates of drug addiction and alcoholismCocaine-induced neuroadaptations in glutamate transmission: potential therapeutic targets for craving and addictionPhase III double-blind, placebo-controlled study of gabapentin for the prevention of delayed chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy, NCCTG N08C3 (Alliance).Latest approaches for the treatment of spasticity and autonomic dysreflexia in chronic spinal cord injuryStreptozotocin-induced early thermal hyperalgesia is independent of glycemic state of rats: role of transient receptor potential vanilloid 1(TRPV1) and inflammatory mediatorsEarly diabetic neuropathy: triggers and mechanisms.Effects of gabapentin on muscle spasticity and both induced as well as spontaneous autonomic dysreflexia after complete spinal cord injuryEffects of axonal ion channel dysfunction on quality of life in type 2 diabetesGlutamatergic medications for the treatment of drug and behavioral addictions.Multiple sites and actions of gabapentin-induced relief of ongoing experimental neuropathic pain.Evidence that pregabalin reduces neuropathic pain by inhibiting the spinal release of glutamateThrombospondin-4 divergently regulates voltage-gated Ca2+ channel subtypes in sensory neurons after nerve injuryThalamic amplification of sensory input in experimental diabetes.Gabapentin Differentially Modulate c-Fos Expression in Hypothalamus and Spinal Trigeminal Nucleus in Surgical Molar Extraction.A comparison of the glutamate release inhibition and anti-allodynic effects of gabapentin, lamotrigine, and riluzole in a model of neuropathic pain.
P2860
Q24648924-45210DF7-1C4D-4DEE-A9CA-B924AEC14166Q33626978-9D4CBAD1-5790-4238-99A7-DFD4D0A58CABQ34458672-73B9BA75-A117-411B-9073-868F12478C24Q35006462-6A309017-46AB-4334-86DC-43B4B9A4C690Q35168721-A292495C-E64F-4D4C-8924-8BEE81CF2F02Q35691425-FD3AC1E9-AACB-48DA-A08E-35A534EDCE02Q36193855-2ABDF275-0C09-4206-A0B7-7F209B790A12Q36782662-B94B1D57-6945-40BC-8ACF-4E80808039B1Q37871133-E9D0672C-E6E0-4945-95CC-2E79B0BA9022Q39150998-0442DBC0-C197-4364-A8BA-6BBF8A4F520BQ41360645-E50396F4-E38C-4AEE-ABC4-1A4FE4055DDDQ41698769-E72DBD15-1512-4C71-9D48-DE53169BF8DDQ42413760-7B89BF34-209D-4A89-B14F-30D314E39076Q48393644-CD4AF387-D376-4B0F-B5CA-1227F1AE3EB0Q48627878-B13FC107-A361-49EC-BE5C-0F60172EA36D
P2860
Reduction by gabapentin of K+-evoked release of [3H]-glutamate from the caudal trigeminal nucleus of the streptozotocin-treated rat.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Reduction by gabapentin of K+- ...... he streptozotocin-treated rat.
@en
Reduction by gabapentin of K+- ...... he streptozotocin-treated rat.
@nl
type
label
Reduction by gabapentin of K+- ...... he streptozotocin-treated rat.
@en
Reduction by gabapentin of K+- ...... he streptozotocin-treated rat.
@nl
prefLabel
Reduction by gabapentin of K+- ...... he streptozotocin-treated rat.
@en
Reduction by gabapentin of K+- ...... he streptozotocin-treated rat.
@nl
P2093
P2860
P356
P1476
Reduction by gabapentin of K+- ...... he streptozotocin-treated rat.
@en
P2093
A T McKnight
N A Andrews
Y P Maneuf
P2860
P304
P356
10.1038/SJ.BJP.0705579
P407
P577
2004-01-26T00:00:00Z